Champions Oncology Statistics
NASDAQ: CSBRHealthcareBiotechnologyUSD
4.98+0.10 (+2.05%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Champions Oncology by the numbers
Champions Oncology has a market capitalization of $69.3 million based on 13.92M shares outstanding. With trailing EPS of $-0.07, Champions Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.8% below its 50-day average and 15.7% below its 200-day average.
Average daily trading volume is 11.33K shares, or about $56,413 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CSBR valuation vs. peer median
| Metric | CSBR | Peer median | Difference |
|---|---|---|---|
| Market cap | $69.31M | $70.09M | -1% |
| Avg. volume | 11.33K | 511.47K | -98% |
Peer median across 8 companies: TENX, FBIO, GANX, HRTX, CING, MAIA, HYFT, ONCY.
Valuation
- Market cap
- $69.31M
- Forward P/E
- 49.80
- EPS (TTM)
- $-0.07
- Shares outstanding
- 13.92M
Price and trading
- Previous close
- 4.88
- Open
- 4.88
- Day range
- 4.88 – 5.00
- 52-week range
- 4.59 – 8.31
- 52-week change
- -23.03%
- Beta
- —
- Volume
- 2.82K
- Average volume
- 11.33K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 10, 2026
Additional statistics
- Market Cap
- 69.31M
- Forward Pe
- 49.80
- Eps
- -0.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.31
- Week52 Low
- 4.59
- Avg Volume
- 11,328.00
- Shares Outstanding
- 13.92M
- Ma50
- 5.07
- Ma200
- 5.91
- Earnings Date
- Sep 10, 2026
- Pct From52w High
- -40.07%
- Pct From52w Low
- 8.50%